ReP USP - Resultado da busca

Artigo de periodico
O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway (2011)
Lima, Victor Vitorino; Giachini, Fernanda Regina Casagrande; Carneiro, Fernando Silva; Carvalho, Maria Helena Catelli de; Fortes, Zuleica Bruno; Webb, R. Clinton; Tostes, Rita C.
Fonte: Cardiovascular Research. Unidades: ICB, FMRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Victor Vitorino et al. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway. Cardiovascular Research, v. 89, n. 3, p. 614-622, 2011Tradução . . Disponível em: https://doi.org/10.1093/cvr/cvq338. Acesso em: 19 abr. 2024.
APA
Lima, V. V., Giachini, F. R. C., Carneiro, F. S., Carvalho, M. H. C. de, Fortes, Z. B., Webb, R. C., & Tostes, R. C. (2011). O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway. Cardiovascular Research, 89( 3), 614-622. doi:10.1093/cvr/cvq338
NLM
Lima VV, Giachini FRC, Carneiro FS, Carvalho MHC de, Fortes ZB, Webb RC, Tostes RC. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway [Internet]. Cardiovascular Research. 2011 ; 89( 3): 614-622.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1093/cvr/cvq338
Vancouver
Lima VV, Giachini FRC, Carneiro FS, Carvalho MHC de, Fortes ZB, Webb RC, Tostes RC. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway [Internet]. Cardiovascular Research. 2011 ; 89( 3): 614-622.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1093/cvr/cvq338
Artigo de periodico
Impaired vasodilator activity in Deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylation (2009)
Lima, Victor V.; Giachini, Fernanda Regina Casagrande; Choi, Hyehun; Carneiro, Fernando Silva; Carneiro, Zidonia N.; Fortes, Zuleica Bruno; Carvalho, Maria Helena Catelli de; Webb, R. Clinton; Passaglia, Rita de Cássia Aleixo Tostes
Fonte: Hypertension. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Victor V. et al. Impaired vasodilator activity in Deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylation. Hypertension, v. 53, n. 2, p. 166-174, 2009Tradução . . Acesso em: 19 abr. 2024.
APA
Lima, V. V., Giachini, F. R. C., Choi, H., Carneiro, F. S., Carneiro, Z. N., Fortes, Z. B., et al. (2009). Impaired vasodilator activity in Deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylation. Hypertension, 53( 2), 166-174.
NLM
Lima VV, Giachini FRC, Choi H, Carneiro FS, Carneiro ZN, Fortes ZB, Carvalho MHC de, Webb RC, Passaglia R de CAT. Impaired vasodilator activity in Deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylation. Hypertension. 2009 ; 53( 2): 166-174.[citado 2024 abr. 19 ]
Vancouver
Lima VV, Giachini FRC, Choi H, Carneiro FS, Carneiro ZN, Fortes ZB, Carvalho MHC de, Webb RC, Passaglia R de CAT. Impaired vasodilator activity in Deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylation. Hypertension. 2009 ; 53( 2): 166-174.[citado 2024 abr. 19 ]
Artigo de periodico
Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats a novel insight into vascular dysfunction (2009)
Giachini, Fernanda Regina Casagrande; Chiao, Chin-Wei; Carneiro, Fernando Silva; Lima, Victor V.; Carneiro, Zidonia N.; Dorrance, Anne M.; Passaglia, Rita de Cássia Aleixo Tostes; Clinton Webb, R.
Fonte: Hypertension. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIACHINI, Fernanda Regina Casagrande et al. Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats a novel insight into vascular dysfunction. Hypertension, v. 53, p. 409-416, 2009Tradução . . Acesso em: 19 abr. 2024.
APA
Giachini, F. R. C., Chiao, C. -W., Carneiro, F. S., Lima, V. V., Carneiro, Z. N., Dorrance, A. M., et al. (2009). Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats a novel insight into vascular dysfunction. Hypertension, 53, 409-416.
NLM
Giachini FRC, Chiao C-W, Carneiro FS, Lima VV, Carneiro ZN, Dorrance AM, Passaglia R de CAT, Clinton Webb R. Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats a novel insight into vascular dysfunction. Hypertension. 2009 ; 53 409-416.[citado 2024 abr. 19 ]
Vancouver
Giachini FRC, Chiao C-W, Carneiro FS, Lima VV, Carneiro ZN, Dorrance AM, Passaglia R de CAT, Clinton Webb R. Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats a novel insight into vascular dysfunction. Hypertension. 2009 ; 53 409-416.[citado 2024 abr. 19 ]
Artigo de periodico
TNF-'alfa' knockout mice have increased corpora cavernosa relaxation (2009)
Carneiro, Fernando Silva; Sturgis, Lashon C.; Giachini, Fernanda R. C.; Carneiro, Zidonia N.; Lima, Victor V.; Wynne, Brandi M.; Martin, Sebastian San; Brands, Michael W.; Passaglia, Rita de Cássia Aleixo Tostes; Webb, R. Clinton
Fonte: Journal of Sexual Medicine. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARNEIRO, Fernando Silva et al. TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine, v. 6, n. 1, p. 115-125, 2009Tradução . . Acesso em: 19 abr. 2024.
APA
Carneiro, F. S., Sturgis, L. C., Giachini, F. R. C., Carneiro, Z. N., Lima, V. V., Wynne, B. M., et al. (2009). TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine, 6( 1), 115-125.
NLM
Carneiro FS, Sturgis LC, Giachini FRC, Carneiro ZN, Lima VV, Wynne BM, Martin SS, Brands MW, Passaglia R de CAT, Webb RC. TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine. 2009 ; 6( 1): 115-125.[citado 2024 abr. 19 ]
Vancouver
Carneiro FS, Sturgis LC, Giachini FRC, Carneiro ZN, Lima VV, Wynne BM, Martin SS, Brands MW, Passaglia R de CAT, Webb RC. TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine. 2009 ; 6( 1): 115-125.[citado 2024 abr. 19 ]
Artigo de periodico
Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension (2008)
Carneiro, Fernando Silva; Nunes, Kênia P.; Giachini, Fernanda Regina Casagrande; Lima, Victor V.; Carneiro, Zidonia N.; Nogueira, Edson F.; Leite, Romulo; Ergul, Adviye; Rainey, William E.; Webb, R.Clinton; Passaglia, Rita de Cássia Aleixo Tostes
Fonte: Journal of Sexual Medicine. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARNEIRO, Fernando Silva et al. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. Journal of Sexual Medicine, v. 5, n. 12, p. 2793-2807, 2008Tradução . . Acesso em: 19 abr. 2024.
APA
Carneiro, F. S., Nunes, K. P., Giachini, F. R. C., Lima, V. V., Carneiro, Z. N., Nogueira, E. F., et al. (2008). Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. Journal of Sexual Medicine, 5( 12), 2793-2807.
NLM
Carneiro FS, Nunes KP, Giachini FRC, Lima VV, Carneiro ZN, Nogueira EF, Leite R, Ergul A, Rainey WE, Webb RC, Passaglia R de CAT. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. Journal of Sexual Medicine. 2008 ; 5( 12): 2793-2807.[citado 2024 abr. 19 ]
Vancouver
Carneiro FS, Nunes KP, Giachini FRC, Lima VV, Carneiro ZN, Nogueira EF, Leite R, Ergul A, Rainey WE, Webb RC, Passaglia R de CAT. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. Journal of Sexual Medicine. 2008 ; 5( 12): 2793-2807.[citado 2024 abr. 19 ]
Artigo de periodico
DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum (2008)
Carneiro, Fernando Silva; Giachini, Fernanda Regina Casagrande; Lima, Victor V.; Carneiro, Zidonia N.; Ergul, Adviye; Leite, Romulo; Webb, R. Clinton; Passaglia, Rita de Cássia Aleixo Tostes; Nunes, Kênia P.
Fonte: Canadian Journal of Physiology and Pharmacology. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARNEIRO, Fernando Silva et al. DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum. Canadian Journal of Physiology and Pharmacology, v. 86, n. 6, p. 320-328, 2008Tradução . . Acesso em: 19 abr. 2024.
APA
Carneiro, F. S., Giachini, F. R. C., Lima, V. V., Carneiro, Z. N., Ergul, A., Leite, R., et al. (2008). DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum. Canadian Journal of Physiology and Pharmacology, 86( 6), 320-328.
NLM
Carneiro FS, Giachini FRC, Lima VV, Carneiro ZN, Ergul A, Leite R, Webb RC, Passaglia R de CAT, Nunes KP. DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum. Canadian Journal of Physiology and Pharmacology. 2008 ; 86( 6): 320-328.[citado 2024 abr. 19 ]
Vancouver
Carneiro FS, Giachini FRC, Lima VV, Carneiro ZN, Ergul A, Leite R, Webb RC, Passaglia R de CAT, Nunes KP. DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum. Canadian Journal of Physiology and Pharmacology. 2008 ; 86( 6): 320-328.[citado 2024 abr. 19 ]
Artigo de periodico
Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer? (2007)
Leite, Romulo; Giachini, Fernanda Regina Casagrande; Carneiro, Fernando Silva; Nunes, Kênia P.; Passaglia, Rita de Cássia Aleixo Tostes; Webb, Robert C.
Fonte: Recent Patents on Cardiovascular Drug Discovery. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Romulo et al. Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer?. Recent Patents on Cardiovascular Drug Discovery, v. 2, n. 2, p. 119-132, 2007Tradução . . Acesso em: 19 abr. 2024.
APA
Leite, R., Giachini, F. R. C., Carneiro, F. S., Nunes, K. P., Passaglia, R. de C. A. T., & Webb, R. C. (2007). Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer? Recent Patents on Cardiovascular Drug Discovery, 2( 2), 119-132.
NLM
Leite R, Giachini FRC, Carneiro FS, Nunes KP, Passaglia R de CAT, Webb RC. Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer? Recent Patents on Cardiovascular Drug Discovery. 2007 ; 2( 2): 119-132.[citado 2024 abr. 19 ]
Vancouver
Leite R, Giachini FRC, Carneiro FS, Nunes KP, Passaglia R de CAT, Webb RC. Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer? Recent Patents on Cardiovascular Drug Discovery. 2007 ; 2( 2): 119-132.[citado 2024 abr. 19 ]

Unidades USP

ReP

Filtros

Autores

Indexado em

Afiliação dos autores externos não normalizada